back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-19 08:49 Tx date 2020-08-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-19 08:48 Tx date 2020-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
250,000 | |
| Filed 2024-01-19 08:45 Tx date 2023-04-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+250,000 vol $0.03 each |
1,000,000 | |
| Filed 2024-01-19 08:43 Tx date 2023-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
1,250,000 | |
| Filed 2024-01-19 08:40 Tx date 2022-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
750,000 | |
| Filed 2024-01-19 08:39 Tx date 2021-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
500,000 | |
| Filed 2024-01-19 08:38 Tx date 2020-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
||
| Filed 2024-01-19 08:34 Tx date 2020-08-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|